12 employees
ZielBio is an early-stage biotechnology company that identifies novel high value disease targets.
2010
$25M
from 2 investors over 2 rounds
ZielBio, Inc. raised $25M on September 26, 2019
Investors: Partners HealthCare and Morningside Venture Capital 晨兴资本